Christoph Massner

Principal, Earlybird Venture Capital

Speaker Bio

Dr. Christoph Massner is Principal at Earlybird Venture Capital's Health Fund, which specialises in digital health, medical devices, diagnostics, R&D platform technologies, and biopharma. He currently sits on the boards of Wellabe and Ariceum Therapeutics and serves as a board observer for Alesi Surgical. Prior to joining Earlybird in 2018, Christoph spent 7+ years conducting research in various laboratories in Germany and Australia and earned his PhD in Synthetic Biology from the Technical University of Munich (TUM).